New publication: Proteomic profiling of the ECM of xenograft breast cancer metastases in different organs reveals distinct metastatic niches
Post date: Feb 4, 2020 8:14:37 PM
In our latest study published in Cancer Research, we used quantitative mass spectrometry to analyze the ECM of triple-negative breast cancer metastases growing in the brain, lungs, liver and bone marrow. Our results show that both tumor and stromal cells cooperated in forming metastatic niches: stromal cells producing predominantly core, structural ECM proteins and tumor cells producing a diverse array of ECM-associated proteins. Additionally, we show that tumor and stromal cells together created distinct niches in different organs.